- Home
- PRTA vs MPX Comparison
PRTA vs MPX Comparison
Compare PRTA & MPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- MPX
- Stock Information
- Founded
- PRTA 2012
- MPX 1965
- Country
- PRTA Ireland
- MPX United States
- Employees
- PRTA N/A
- MPX N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- MPX Marine Transportation
- Sector
- PRTA Health Care
- MPX Industrials
- Exchange
- PRTA Nasdaq
- MPX Nasdaq
- Market Cap
- PRTA 346.4M
- MPX 297.8M
- IPO Year
- PRTA N/A
- MPX N/A
- Fundamental
- Price
- PRTA $6.29
- MPX $8.36
- Analyst Decision
- PRTA Buy
- MPX Hold
- Analyst Count
- PRTA 9
- MPX 1
- Target Price
- PRTA $27.67
- MPX $8.00
- AVG Volume (30 Days)
- PRTA 1.3M
- MPX 24.4K
- Earning Date
- PRTA 08-07-2025
- MPX 07-24-2025
- Dividend Yield
- PRTA N/A
- MPX 6.41%
- EPS Growth
- PRTA N/A
- MPX N/A
- EPS
- PRTA N/A
- MPX 0.43
- Revenue
- PRTA $137,935,000.00
- MPX $226,217,000.00
- Revenue This Year
- PRTA N/A
- MPX $3.97
- Revenue Next Year
- PRTA $122.02
- MPX $13.02
- P/E Ratio
- PRTA N/A
- MPX $19.71
- Revenue Growth
- PRTA 54.55
- MPX N/A
- 52 Week Low
- PRTA $4.32
- MPX $7.49
- 52 Week High
- PRTA $25.42
- MPX $10.89
- Technical
- Relative Strength Index (RSI)
- PRTA 56.80
- MPX 46.57
- Support Level
- PRTA $6.16
- MPX $8.40
- Resistance Level
- PRTA $6.60
- MPX $9.30
- Average True Range (ATR)
- PRTA 0.27
- MPX 0.29
- MACD
- PRTA 0.04
- MPX -0.06
- Stochastic Oscillator
- PRTA 67.90
- MPX 11.11
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.